Differences between the European and Eurasian Good Pharmacovigilance Practices
Good pharmacovigilance practices (GVP) of the Eurasian Economic Union (EAEU) were prepared based on the GVP of the European Medicines Agency that have been in force in the European Union (EU) since 2012. The EAEU GVP have been in force in the Russian Federation and the other EAEU member states since...
Saved in:
| Main Authors: | A. V. Matveev, A. E. Krasheninnikov, E. A. Matveeva, B. K. Romanov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2021-07-01
|
| Series: | Безопасность и риск фармакотерапии |
| Subjects: | |
| Online Access: | https://www.risksafety.ru/jour/article/view/220 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Changes to the EAEU Guideline on Good Pharmacovigilance Practices
by: B. K. Romanov
Published: (2023-03-01) -
Good Pharmacovigilance Practice in the United States and the European Union
by: V. A. Merkulov, et al.
Published: (2022-06-01) -
Risk Management Plan: An Expert Analysis of Changes to the EAEU Good Pharmacovigilance Practice Requirements for the Content and Submission of the Document
by: T. M. Bukatina, et al.
Published: (2023-03-01) -
New Edition of the EAEU Good Pharmacovigilance Practice: What Has Changed?
by: D. A. Rozhdestvensky
Published: (2023-03-01) -
Rate Setting for Labour Costs Related to Pharmacovigilance System Inspections
by: M. Abdrakhmanov, et al.
Published: (2022-04-01)